XML 104 R23.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Shareholders' Equity
 12 Months Ended
Dec. 31, 2019
Equity [Abstract]  
Shareholders' Equity Shareholders’ Equity

Share Repurchases. On March 26, 2019, the Company announced that its Board had authorized a share repurchase program, enabling the repurchase of up to $50 million of its Class A ordinary shares through August 31, 2020. In addition, on November 21, 2019, the Company announced that its Board had authorized the repurchase of an additional $50 million of its Class A ordinary shares through December 31, 2020. Share repurchases under the authorized plans could be effected on behalf of the Company through open market transactions, privately negotiated transactions, or otherwise, pursuant to SEC trading rules.

From May through September 2019, the Company repurchased an accumulated total of 1,732,392 outstanding Class A ordinary shares at a weighted average price of $28.86 per share, for an aggregate purchase price of approximately $50 million, exhausting the March 2019 authorization. The Company did not utilize the second authorization to repurchase shares in the three months ended December 31, 2019. The amounts presented for share repurchases on the Consolidated Statements of Shareholders' Equity include the applicable stamp taxes payable in the U.K. of $0.3 million.
Common shares. The Company had 44,676,132 and 46,134,381 shares outstanding as of December 31, 2019 and 2018, respectively.
Additional paid-in capital. Included in the balance of Additional paid-in capital are amounts related to the Convertible Notes issued in November 2013 and the related equity instruments. These amounts include: (i) the estimated fair value of the embedded option of the Convertible Notes of $71.7 million at the time of issuance, (ii) the amount paid to purchase the associated convertible note hedges of $72.6 million, (iii) the amount received for selling associated warrants of $40.5 million, and (iv) $1.6 million in debt issuance costs allocated to the equity component of the convertible note. For additional information related to the Convertible Notes and the related equity instruments, see Note 11. Long-Term Debt.
Accumulated other comprehensive loss, net. Accumulated other comprehensive loss, net, is a separate component of Shareholders’ equity in the accompanying Consolidated Balance Sheets. The following table presents the changes in the balances of each component of Accumulated other comprehensive loss, net for the years ended December 31, 2019, 2018, and 2017:
 
Foreign Currency Translation Adjustments
     
Unrealized (Losses) Gains on Interest Rate Swap and Foreign Currency Forward Contracts
     
Total
 
(In thousands)
Total Accumulated other comprehensive loss, net as of December 31, 2016
$
(80,885
)
(5) 
$
(26,250
)
(1) 
$
(107,135
)
Other comprehensive income (loss) before reclassification
56,511

(6) 
(3,007
)
(2) 
53,504

Amounts reclassified from accumulated other comprehensive loss, net
—

 
20,036

(2) 
20,036

Net current period other comprehensive income
56,511

 
17,029

 
73,540

Total Accumulated other comprehensive loss, net as of December 31, 2017
$
(24,374
)
(5) 
$
(9,221
)
(1) 
$
(33,595
)
 
 
 
 
 
 
Other comprehensive (loss) income before reclassification
(41,938
)
(6) 
4,725

(3) 
(37,213
)
Amounts reclassified from accumulated other comprehensive loss, net
—

 
3,931

(3) 
3,931

Net current period other comprehensive (loss) income
(41,938
)
 
8,656

 
(33,282
)
Total Accumulated other comprehensive loss, net as of December 31, 2018
$
(66,312
)
(5) 
$
(565
)
(1) 
$
(66,877
)
Other comprehensive income (loss) before reclassification
7,627

(6) 
(20,311
)
(4) 
(12,684
)
Amounts reclassified from Accumulated other comprehensive loss, net
(458
)
(7) 
2,132

(4) 
1,674

Net current period other comprehensive income (loss)
7,169

 
(18,179
)
 
(11,010
)
Total Accumulated other comprehensive loss, net as of December 31, 2019
$
(59,143
)
(5) 
$
(18,744
)
(1) 
$
(77,887
)

(1)
Net of deferred income tax expense of $14,273, $19,112, $16,317, and $9,269 as of December 31, 2019, 2018, 2017, and 2016 respectively.
(2)
Net of deferred income tax (benefit) expense of ($1,245) and $8,295 for Other comprehensive income (loss) before reclassification and Amounts reclassified from Accumulated other comprehensive loss, net, respectively, for the year ended December 31, 2017. See Note 16. Derivative Financial Instruments.
(3)
Net of deferred income tax expense of $1,525 and $1,270 for Other comprehensive (loss) income before reclassification and Amounts reclassified from Accumulated other comprehensive loss, net, respectively, for the year ended December 31, 2018. See Note 16. Derivative Financial Instruments.
(4)
Net of deferred income tax (benefit) expense of ($5,407) and $568 for Other comprehensive income (loss) before reclassification and Amounts reclassified from Accumulated other comprehensive loss, net, respectively, for the year ended December 31, 2019. See Note 16. Derivative Financial Instruments.
(5)
Net of deferred income tax benefit of ($5,474), ($5,232), ($5,339), ($4,113) as of December 31, 2019, 2018, 2017, and 2016 respectively.
(6)
Net of deferred income tax (benefit) expense of ($242), $107, and ($1,226) for the years ended December 31, 2019, 2018, and 2017, respectively.
(7)
The Company reclassified a gain of $0.5 million from Accumulated other comprehensive loss, net in 2019, upon liquidation of the Poland legal entity.
The Company records unrealized gains and losses related to its designated interest rate swap, cap and foreign currency forward, net of estimated taxes, in the Accumulated other comprehensive loss, net line in the accompanying Consolidated Balance Sheets since it is more likely than not that the Company will be able to realize the benefits associated with its net deferred tax asset positions in the future. The amounts reclassified from Accumulated other comprehensive loss, net are recognized in the Cost of ATM operating revenues line in the accompanying Consolidated Statements of Operations.
The Company has elected the portfolio approach for the deferred tax asset of the unrealized gains and losses related to the designated interest rate swap, cap and foreign currency forward contracts in Accumulated other comprehensive loss, net within the accompanying Consolidated Balance Sheets. Under the portfolio approach, the disproportionate tax effect created when the valuation allowance was appropriately released as a tax benefit into continuing operations in 2010, will reverse out of the Accumulated other comprehensive loss, net line in the accompanying Consolidated Balance Sheets and into continuing operations as a tax expense when the Company ceases to hold any designated interest rate swap, cap or forward contracts. As of December 31, 2019, the disproportionate tax effect is $14.6 million.
The Company currently believes that the unremitted earnings of certain of its subsidiaries will be reinvested for an indefinite period of time. Accordingly, no deferred taxes have been provided for the differences between the Company’s book basis and underlying tax basis in these subsidiaries or on the foreign currency translation adjustment amounts.